Literature DB >> 19246184

Lung clearance index in the assessment of airways disease.

Alex Horsley1.   

Abstract

In the last few years there has been a growing interest in lung clearance index (LCI), a measure of lung physiology derived from multiple breath washout tests. This resurgence of interest was initially driven by the recognition that such assessments were capable of detecting early airways disease in children, and are more sensitive and easier to perform in this population than conventional lung function tests [Aurora P, Kozlowska W, Stocks J. Gas mixing efficiency from birth to adulthood measured by multiple-breath washout. Respir Physiol Neurobiol, 2005;148(1-2):125-39]. With an appreciation of the importance of earlier identification of airways dysfunction, and prevention of irreversible structural airway changes, methods of following airways disease in these "silent years" are especially important. LCI has now been reported in studies involving all age groups, from infants to adults [Lum S, Gustafsson P, Ljungberg H, Hulskamp G, Bush A, Carr SB, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax, 2007;62(4):341-7; Horsley AR, Gustafsson PM, Macleod K, Saunders CJ, Greening AP, Porteous D, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax, 2008;63:135-40], and has a narrow range of normal over this wide age range, making it especially suitable for long-term follow-up studies. In cystic fibrosis (CF) particularly, there is a pressing need for sensitive and repeatable clinical endpoints for therapeutic interventions [Rosenfeld M. An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thorac Soc, 2007;4(4):299-301], and LCI has been proposed as an outcome measure in future CF gene therapy studies [Davies JC, Cunningham S, Alton EW, Innes JA. Lung clearance index in CF: a sensitive marker of lung disease severity. Thorax, 2008;63(2):96-7]. This review will consider how LCI is derived, how it differs from conventional lung function testing, and its applications and limitations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246184     DOI: 10.1016/j.rmed.2009.01.025

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  39 in total

1.  Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

Authors:  BreAnna Kinghorn; Sharon McNamara; Alan Genatossio; Erin Sullivan; Molly Siegel; Irma Bauer; Charles Clem; Robin C Johnson; Miriam Davis; Anne Griffiths; William Wheeler; Katherine Johnson; Stephanie D Davis; Margaret W Leigh; Margaret Rosenfeld; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2020-09

Review 2.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

3.  A new infant hybrid respiratory simulator: preliminary evaluation based on clinical data.

Authors:  Barbara Stankiewicz; Krzysztof J Pałko; Marek Darowski; Krzysztof Zieliński; Maciej Kozarski
Journal:  Med Biol Eng Comput       Date:  2017-03-25       Impact factor: 2.602

4.  Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations.

Authors:  Hartmut Grasemann; Pierluigi Ciet; Reshma Amin; Nancy McDonald; Michelle Klingel; Harm A W M Tiddens; Felix Ratjen; Lars Grosse-Wortmann
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

5.  Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.

Authors:  Lauren M Zell-Baran; Silpa D Krefft; Camille M Moore; Jenna Wolff; Richard Meehan; Cecile S Rose
Journal:  Respir Med       Date:  2020-12-05       Impact factor: 3.415

6.  Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.

Authors:  Michal Gur; Karin Yaacoby-Bianu; Anat Ilivitzki; Ronen Bar-Yoseph; Vered Nir; Fahed Hakim; Yazeed Toukan; Lea Bentur
Journal:  Lung       Date:  2016-08-31       Impact factor: 2.584

7.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

Review 8.  Question 3: Can we diagnose asthma in children under the age of 5 years?

Authors:  C L Yang; J M Gaffin; D Radhakrishnan
Journal:  Paediatr Respir Rev       Date:  2018-10-24       Impact factor: 2.726

9.  Using Hyperpolarized 129Xe MRI to Quantify the Pulmonary Ventilation Distribution.

Authors:  Mu He; Bastiaan Driehuys; Loretta G Que; Yuh-Chin T Huang
Journal:  Acad Radiol       Date:  2016-09-09       Impact factor: 3.173

10.  Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia.

Authors:  Samantha J Irving; Andrew Ives; Gwyneth Davies; Jackie Donovan; Anthony J Edey; Simon S Gill; Arjun Nair; Clare Saunders; Nevin T Wijesekera; Eric W F W Alton; David Hansell; Claire Hogg; Jane C Davies; Andrew Bush
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.